Scenesse afamelanotide regulatory update

Clinuvel said it received Orphan Drug designation for its Scenesse afamelanotide in the U.S. and EU to treat Hailey-Hailey disease (HHD), a rare inherited skin disorder characterized by periodic eruption of plaque-like lesions and blisters on areas where skin folds. The sustained-release subcutaneous implant of synthetic alpha melanocyte stimulating hormone (MSH) is in an Italian Phase II trial for HHD. ...